Lab Automation for In-vitro Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Lab Automation for In-Vitro Diagnostics Market is Segmented by Equipment (automated Plate Handler, Automated Liquid Handler, Robotic Arm, Automated Storage, And Retrieval System and Analyzer), End User (academic and Laboratory), And Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The Report Offers the Market Size in Value Terms in USD for all the Abovementioned Segments.

Lab Automation for In-vitro Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Lab Automation For In-Vitro Diagnostics Industry Overview

The Lab Automation For In-Vitro Diagnostics Market is highly fragmented with the presence of major players like Cognex Corporation, Roche Holding AG, Thermo Fisher Scientific Inc., Danaher Corporation, and Agilent Technologies Inc. Players in the market are adopting strategies such as partnerships and acquisitions to enhance their product offerings and gain sustainable competitive advantage.

  • August 2023 - Roche Diagnostics, the diagnostic business unit of F. Hoffmann-La Roche, and Japanese diagnostics company Sysmex have expanded their existing global business partnership agreement. As part of the updated framework, the companies reaffirm their commitment to their long-standing collaboration. 
  • May 2023 - Werfen signed a new long-term partnership agreement with Thermo Fisher Scientific for the global distribution of a TCAutomation laboratory automation system in the specialized field of Hemostasis Diagnostics. 

Lab Automation For In-Vitro Diagnostics Market Leaders

  1. Cognex Corporation

  2. Roche Holding AG

  3. Thermo Fisher Scientific Inc.

  4. Danaher Corporation

  5. Siemens Healthineers AG

  6. *Disclaimer: Major Players sorted in no particular order
Lab Automation For In-Vitro Diagnostics Market Conc.jpg